L-arginine
- Generic Name
- L-arginine
- Brand Names
- Clinimix 2.75/5
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 74-79-3
- Unique Ingredient Identifier
- -
- Associated Conditions
- -
- Associated Therapies
- -
Effects of Oral L-Arginine on Chronic Hypertension in Pregnancy
- First Posted Date
- 2007-12-12
- Last Posted Date
- 2009-09-10
- Lead Sponsor
- University of Modena and Reggio Emilia
- Target Recruit Count
- 80
- Registration Number
- NCT00571766
- Locations
- 🇮🇹
University of Modena and Reggio Emilia, Modena, Emilia Romagna, Italy
Prevention of Cardiac and Vascular Events in Patients With NGT/IGT.
- Conditions
- First Posted Date
- 2006-12-07
- Last Posted Date
- 2006-12-12
- Lead Sponsor
- IRCCS San Raffaele
- Target Recruit Count
- 150
- Registration Number
- NCT00408577
- Locations
- 🇮🇹
Scientific Institute San Raffaele, Milan, Italy
The Short Term Safety and Efficacy of Inhaled L-arginine in Patients With Cystic Fibrosis
- First Posted Date
- 2006-11-30
- Last Posted Date
- 2013-09-02
- Lead Sponsor
- The Hospital for Sick Children
- Target Recruit Count
- 20
- Registration Number
- NCT00405665
- Locations
- 🇨🇦
The Hospital for Sick Children, Toronto, Ontario, Canada
🇨🇦St. Michael's Hospital, Toronto, Ontario, Canada
L-Arginine in the Treatment of Peripheral Arterial Disease
- Conditions
- First Posted Date
- 2006-01-31
- Last Posted Date
- 2014-03-05
- Lead Sponsor
- Stanford University
- Registration Number
- NCT00284076
Effects of L-arginine Supplementation in Adults With Moderate to Severe Asthma
- First Posted Date
- 2006-01-23
- Last Posted Date
- 2017-05-30
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 20
- Registration Number
- NCT00280683
- Locations
- 🇺🇸
University of California, Davis General Clinical Research Center, Sacramento, California, United States
L-Arginine in Pre-Eclampsia
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2006-12-22
- Target Recruit Count
- 30
- Registration Number
- NCT00157521
- Locations
- 🇮🇹
Obstetrics and Ginecology Division, Brescia, Italy
🇮🇹Hospital "Ospedali Riuniti", Unit of Obstetrics and Ginecology, Bergamo, Italy
L-Arginine Metabolism in Essential Hypertension
- Conditions
- First Posted Date
- 2005-08-29
- Last Posted Date
- 2012-07-10
- Lead Sponsor
- University of Erlangen-Nürnberg Medical School
- Target Recruit Count
- 120
- Registration Number
- NCT00137124
- Locations
- 🇩🇪
CRC, Medizinische Klinik 4 - Nephrology and Hypertension, University of Erlangen-Nürnberg, Erlangen, Germany
Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia
- Conditions
- First Posted Date
- 2003-03-13
- Last Posted Date
- 2019-11-22
- Target Recruit Count
- 39
- Registration Number
- NCT00056433
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Vascular Interaction With Age in Myocardial Infarction
- Conditions
Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women
- Conditions
- First Posted Date
- 2002-12-10
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 30
- Registration Number
- NCT00001752
- Locations
- 🇺🇸
National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.